CHRM1 and liver disorder: This intriguing paradigm is supported by our discovery of additional instances where M1R and M3R have diametrically divergent effects; for example, whereas activation of M3R in murine models of advanced liver disease promotes fibrosis and advanced disease, M1R activation mitigates liver scarring.